SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Nov 10, 2010
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: Nov. 10, 2010 · CIK: 0001326205 · Accession: 0001185185-10-001237
AI Filing Summary & Sentiment
File numbers found in text: 333-163867
Show Raw Text
CORRESP
1
filename1.htm
indiaglobal-2corresp111010.htm
SOURCE CAPITAL GROUP, INC.
276 POST ROAD WEST
WESTPORT, CT 06880
November 10, 2010
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Pamela A. Long
Assistant Director
Division of Corporation Finance
Re:
India Globalization Capital, Inc.
Registration Statement on Form S-1
Registration Statement No. 333-163867
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Source Capital Group, Inc., as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m., Washington D.C. time, on November 10, 2010, or as soon thereafter as practicable.
Sincerely,
/s/Richard H. Kreger
Richard H. Kreger
Senior Managing Director